FDA approvals and label changes.
出版信息
AIDS Patient Care STDS. 2009 Jul;23(7):578-9. doi: 10.1089/apc.2009.9922.
PMID:19621996
Abstract
摘要
相似文献
1
FDA approvals and label changes.
AIDS Patient Care STDS. 2009 Jul;23(7):578-9. doi: 10.1089/apc.2009.9922.
2
FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
AIDS Alert. 2003 Jan;18(1):10-1.
3
Recent FDA approvals and changes.
AIDS Patient Care STDS. 2010 Jun;24(6):396-7.
4
FDA notifications. FDA approves label change for nevirapine.
AIDS Alert. 2008 Aug;23(8):91-2.
5
A look ahead at this year's drug approvals.
Proj Inf Perspect. 2007 Apr(43):4-7.
6
FDA regulations. FDA shuts down sale of unregulated HIV drug.
AIDS Policy Law. 2004 Sep 24;19(18):8.
7
HIV drugs. FDA new drug approval rate lowest in 10 years.
AIDS Policy Law. 2007 Jan 26;22(2):5.
8
1992 FDA drug approvals.
Gen Dent. 1993 Jul-Aug;41(4):286-7.
9
FDA notifications. Tentative approval granted for combo antiretroviral drug.
AIDS Alert. 2007 Oct;22(10):117-8.
10
FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert. 2009 Sep;24(9):106-7.
Zotero 插件